Interactions of ACEA and WIN 55,212-2 mesylate with temozolomide and cisplatin in neuroblastoma and glioblastoma cell lines: an isobolographic analysis

This publication has 73 references indexed in Scilit:

• Initial chemotherapy dose reductions and subsequent treatment delivery in stage I–IIIA breast cancer
  Cancer, 2026
• Unraveling the Molecular Mechanisms of Glioma Recurrence: A Study Integrating Single‐Cell and Spatial Transcriptomics
  Annals of Clinical and Translational Neurology, 2026
• Recent Advances in the Therapeutic Potential of Cannabinoids Against Gliomas: A Systematic Review (2022–2025)
  Pharmacology Research & Perspectives, 2025
• Current status of precision oncology in adult glioblastoma
  Molecular Oncology, 2024
• Glioblastoma and Other Primary Brain Malignancies in Adults
  JAMA, 2023
• Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of cytotoxic chemotherapy and other cytotoxic therapies in the management of progressive glioblastoma in adults
  Journal of Neuro-Oncology, 2022
• Drug Combinations: Tests and Analysis with Isoboles
  Current Protocols in Pharmacology, 2016
• Cannabinoid and cannabinoid‐like receptors in microglia, astrocytes, and astrocytomas
  Glia, 2010
• Synthetic cannabinoid WIN55,212‐2 inhibits generation of inflammatory mediators by IL‐1β‐stimulated human astrocytes
  Glia, 2004
• Novel, Not Adenylyl Cyclase-Coupled Cannabinoid Binding Site in Cerebellum of Mice
  Biochemical and Biophysical Research Communications, 2002